Hepatitis C symptoms and diagnosis

Hepatitis C symptoms and diagnosis features

• 

  The new epidemic: HIV and hepatitis C infection in gay men

  “I’m surprised there isn’t a greater sense of urgency about this in the community.” Those were the words of Dr Kevin Fenton of the US Centers for...

  From:  HIV treatment update

• 

  Management of HIV and hepatitis B or C co-infection in resource-limited settings

  Review of management of HIV and hepatitis co-infection with particular focus on antiretroviral therapy and liver disease in resource-limited settings....

  From:  HIV & AIDS treatment in practice

Hepatitis C symptoms and diagnosis in your own words

• 

  Living with HIV and hep C co-infection and haemophilia

  For most people, coping with HIV is enough of a problem in itself, but when you throw in a lifetime disorder such as haemophilia, and...

  From:In your own words

Hepatitis C symptoms and diagnosis news from aidsmap

• Spanish research shows that liver stiffness can predict outcomes in people co-infected with HIV and hepatitis C

  Liver stiffness is a strong predictor of hepatic complications and all-cause mortality in people co-infected with HIV and hepatitis C virus (HCV), Spanish investigators report in the online edition of AIDS. Liver stiffness was assessed using an ultrasound-based technique ...

  30 January 2013 | Michael Carter

• New cohort shows the impact of hepatitis B and hepatitis C on the 'baby boom' generation

  A new US study provides more evidence of the disproportionate impact of viral hepatitis infections on the 'baby boom' generation. Writing in the online edition of Clinical Infectious Diseases, investigators from the newly established Chronic Hepatitis Cohort Study (CHeCS) ...

  11 November 2012 | Michael Carter

• Bacterial translocation is associated with more severe liver fibrosis in HIV/hepatitis C-co-infected people

  The presence of intestinal bacteria in blood (bacterial translocation) is associated with more severe liver disease in people who are co-infected with HIV and hepatitis C virus, Spanish investigators report in the online edition of the Journal of Acquired ...

  13 September 2012 | Michael Carter

• New US guidelines recommend hepatitis C test for everyone born between 1945 and 1965

  Anyone born between 1945 and 1965 should be tested for hepatitis C virus (HCV), according to new guidance released by the US Centers for Disease Control and Surveillance (CDC). The guidance quotes research showing that prevalence of hepatitis C ...

  21 August 2012 | Michael Carter

• Decompensated liver disease more frequent in HIV/HCV co-infected people

  Despite effective antiretroviral therapy, people co-infected with HIV and hepatitis C remain at higher risk for decompensated liver disease and other liver-related complications than those with hepatitis C alone, according to findings presented on Wednesday at the 19th International AIDS ...

  26 July 2012 | Liz Highleyman

• Insulin resistance is a big risk factor for the progression of liver fibrosis in HIV/HCV co-infected people

  Insulin resistance is associated with the progression of liver fibrosis in people co-infected with HIV and hepatitis C, Canadian researchers report in the online edition of AIDS. Earlier research has shown that hepatitis C virus (HCV) infection is associated ...

  13 July 2012 | Michael Carter

• Doctors in Europe and the US disagree over the pace of liver fibrosis in men co-infected with HIV and hepatitis C

  Doctors in Europe and the US have conflicting opinions about the pace of liver fibrosis in HIV-positive men with hepatitis C infection. In a study published in Clinical Infectious Diseases, European investigators showed that the pace of liver fibrosis ...

  13 June 2012 | Michael Carter

• Hepatitis C testing rate low and knowledge of the infection poor in the US "baby boomer" generation

  Only a quarter of US individuals in the generation most likely to have hepatitis C have ever been tested for the infection, results of a survey conducted by the American Gastroenterological Association (AGA) show. Moreover, 80% of patients in ...

  18 May 2012 | Michael Carter

• Brivanib did not improve overall liver cancer survival, but did show anti-tumour activity

  The experimental cancer drug brivanib did not lengthen overall survival for patients with hepatocellular carcinoma, but it did increase time to progression, demonstrating that it had anti-tumour activity, researchers reported at the 47th International Liver Congress (EASL 2012) last week ...

  30 April 2012 | Liz Highleyman

• Discordance between CD4 cell count and percentage associated with markers of liver disease in HIV/hepatitis C co-infected people

  Discordance between CD4 cell count and CD4 cell percentage in people co-infected with HIV and hepatitis C is associated with markers of liver fibrosis and other indicators of liver dysfunction, Canadian investigators report in the online edition of Clinical ...

  09 April 2012 | Michael Carter

More news

Hepatitis C symptoms and diagnosis news selected from other sources

• Expanding High Risk Population Drives European Hepatitis B and C Diagnostics Market

  New analysis from Frost & Sullivan, Analysis of the European Hepatitis B and C Diagnostics Market, estimates revenues of the hepatitis B diagnostics to grow from $165.9 million in 2012 to $260.2 million in 2019 and hepatitis C diagnostics market to grow from $3,140.8 million in 2012 to $4,940.9 million in 2019, respectively.

  13 March 2013 | PR Newswire (press release)

• 'Hepatitis C detector' promises hope and nothing more

  Wherever people are confronted with serious threats and a lack of solutions there is a potential market in false hope.

  05 March 2013 | The Guardian

• HIV Accelerates Liver Fibrosis by Nearly a Decade Among People With Hep C

  Fibrosis in those coinfected with hepatitis C and HIV is comparable in severity to that found in people mono- infected with hep C who are nearly a decade older.

  01 March 2013 | Aidmeds

• Addressing Hepatitis C Disparities in the African American Community

  African Americans are twice as likely to be infected with the hepatitis C virus (HCV) compared to the general U.S. population, according to the CDC.

  01 March 2013 | Google Alerts - Hepatitis

• Launch of New Patient-Focused Website at LiverCancerConnect.org

  The website aims to help people better understand how liver cancer is diagnosed and how it can be treated or prevented. In addition, wwwLiverCancerConnect.org includes a Drug Watch of potential new liver cancer therapies, an expanding directory of liver cancer specialists, and a clinical trials listing.

  07 February 2013 | Hepatitis B Foundation

• The Age-Old Debate of Whether to Biopsy in HCV: My Answer for 2013

  Mark Sulkowski MD discusses the role of liver biopsy in the management of the HCV patient.

  25 January 2013 | Clinical Care Options (requires registration)

• Rapid pace of liver damage in recent HCV co-infection

  The research suggests that HIV-positive people who later become co-infected with HCV are at risk for an accelerated pace of liver damage, perhaps caused by underlying immunological dysfunction.

  21 January 2013 | CATIE

• Year in Review: Dueling HCV Screening Recommendations

  As part of the Year in Review series, MedPage Today reporters are revisiting major news stories and following up with an analysis of the impact of the original report, as well as subsequent news on the topic. In terms of hepatitis C screening recommendations, there's been controversy and concern.

  03 January 2013 | MedPage Today

• UAE to launch Hep-C awareness

  The region's first Hepatitis C national awareness campaign was launched in the UAE to raise awareness and encourage UAE residents to be screened for Hepatitis C.

  21 December 2012 | Bahrain News Agency

• Hepatitis C Reaching Crisis Levels; Requires Coverage for Routine Screenings

  As the countdown to implementation of the Affordable Care Act begins in earnest, experts on the front lines in fighting viral hepatitis and HIV/AIDS issued this harsh assessment regarding escalating levels of hepatitis C virus (HCV) infection: unless policymakers require insurers to cover the costs of screening everyone at potential risk for HCV, rates of cirrhosis and liver cancer will continue to rise and become a major drain on the healthcare system.

  28 November 2012 | National Summit on HIV and Viral Hepatitis press release

More news